Cochlear Limited

A$155.47As of Sun 8 Nov 2026, 12:00 UTC
ASX:COHHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR 3.51%
Div yield 1.67%
ROE 7.98%
Medical Devices
Beta (5Y) 0.24
PE TTM 69.16
TSR TTM (44.64%)
Mkt cap A$10.17B
ROIC 16.44%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$183
17.82%
(10.23%)
Buy 10|0|9|7|2
2Q26
3Q26
4Q26
1Q27
Earnings per share$
1.42
1.39
1.46
1.47
(2.12%)
(5.16%)
4.84%
3.17%
Revenue$M
805.3
784.2
812.2
852.6
4.89%
3.65%
2.13%
8.65%
Peers (US$6.983B)
Cap (US$)
PE
4.352B
21.77x
422.3M
84.76x
Capital
TTM
5Y
10Y
Leveragex
2.098
(1.197)
(1.110)
EBIT/Intx
0.787
0.201
0.163
Own earn%
(49.52)
(88.84)
(104.41)
Sh yield%
22.45
40.65
41.22
Owners
Insiders/Inst%
14.37
52.04
Short interest%
4.22
SBC / revenue%
3.57
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
18–26
$1 testx
0.0
Incr. ROIC%
11